Answers are grounded in this paper and cite their sources.
SUMMARY Numerous intravenous fluid preparations are available for administration to patients in the clinical setting. These fluids have traditionally been described as either crystalloid or colloid but they may be further classified according to the nature of the solution itself, i.e. 0.9% NaCl (normal saline) or balanced salt‐based fluids (e.g., lactated Ringer's solution). Until recently, little attention has been paid to the potential systemic effects of intravenous fluids that occur independently of their efficacy as agents for intravascular volume replacement. This article explores the available data regarding the impact of intravenous fluids on the kidney to determine whether there is any evidence linking intravenous fluid administration and the pathogenesis of renal dysfunction or renal failure. Particular reference is made to 0.9% NaCl and the hydroxyethylstarch solutions but other fluids such as gelatin and dextran are also considered. In addition, the metabolic effects of intravenous fluids are discussed as these may influence the choice of fluid type in patients with impaired renal function and renal failure.
No takes yet. Share an insight, caveat, or question.
Catherine O’Malley (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: